April 9, 2012 — New research published in the April issue of The Journal of Nuclear Medicine reveals that systemic ...
PET Imaging
Positron emission tomography (PET) is a nuclear imaging technology (also referred to as molecular imaging) that enables visualization of metabolic processes in the body. The basics of PET imaging is that the technique detects pairs of gamma rays emitted indirectly by a positron-emitting radionuclide (also called radiopharmaceuticals, radionuclides or radiotracer). The tracer is injected into a vein on a biologically active molecule, usually a sugar that is used for cellular energy. PET systems have sensitive detector panels to capture gamma ray emissions from inside the body and use software to plot to triangulate the source of the emissions, creating 3-D computed tomography images of the tracer concentrations within the body.
April 6, 2012 – The U.S. Food and Drug Administration (FDA) has approved the first diagnostic agent to image Alzheimer’s ...
April 6, 2012 — Positron Corp. announced the approval of its Nuclear Regulatory Commission (NRC) manufacturing and ...
Digital technology is opening remarkable opportunities for clinical positron emission tomography (PET) about which ...
March 22, 2012 – Addressing concerns over radiation from cardiac imaging and procedures, the American College of ...
March 16, 2012 — Novelos Therapeutics Inc. announced that the University of Wisconsin Carbone Cancer Center, a medical ...
March 9, 2012 — Researchers from Boca Raton Regional Hospital in Boca Raton, Fla., showed that the FDG dose for positron ...
Precision can have an enormous impact on patients. From diagnosis to patient monitoring (see “How Digital PET/CT Can ...
March 6, 2012 — Imaging amino acid transporters with positron emission tomography/computed tomography (PET/CT) has been ...
March 5, 2012 — SciFluor Life Sciences announced an agreement with Harvard University that extends its license of ...
February 16, 2012 — Siemens Healthcare announced that the U.S. Food and Drug Administration (FDA) recently cleared the ...
PET is getting ready to venture outside oncology, cardiology and mainstream neurology. High on the list of new clinical ...
February 13, 2012 — In two new studies featured in the February issue of The Journal of Nuclear Medicine, researchers ...
We have entered a time in this country when more powerful is not necessarily better, when we can do more than we need to ...
January 30, 2012 — Positron Corp., a molecular imaging healthcare company specializing in the field of nuclear ...
Analog is approximate. Digital is specific. Therein lies the fundamental difference between digital PET and its analog ...
January 20, 2012 – Nuclear cardiology imaging company Positron Corp. this week acquired Manhattan Isotope Technology LLC ...
January 13, 2012 – The U.S. Food and Drug Administration (FDA) is updating healthcare professionals and the public about ...
January 12, 2012 — UT-Southwestern Medical Center in Dallas, Texas, has acquired and installed a high-resolution ...
January 6, 2012 – Bracco Diagnostics said it plans to close out the recall process for its CardioGen-82 cardiac ...
January 5, 2012 – During RSNA 2011, TeraRecon Inc. demonstrated a suite of innovative tools for its iNtuition solution ...
December 28, 2011 — Mirada Medical will demonstrate their software magnetic resonance/positron emission tomography (MR ...
December 16, 2011 — Positron Corp. announced this week that on Dec. 12, 2011, its Attrius & Attrius L positron emission ...
December 13, 2011 – During RSNA 2011, Bracco explained it is working with the U.S. Food and Drug Administration (FDA) to ...
April 09, 2012 